What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...

Join a community dedicated to innovative cardiovascular care, where every role contributes to our mission of transforming heart health. Explore opportunities that not only advance your career but also ...

Multimodality imaging can identify papillary muscles that are the source of arrhythmias. Increased echogenicity, gadolinium enhancement, and calcifications on papillary muscles can indicate site of ...

Early increases in CRP during immune checkpoint inhibitor (ICI) therapy are linked to a higher risk of venous thromboembolism (VTE). CRP trajectories could serve as biomarkers for assessing VTE risk ...

The following are key points to remember from a state-of-the-art review on cardiovascular (CV) risk in prostate cancer (PC): ...

Chlorthalidone is not superior to hydrochlorothiazide in preventing kidney disease progression in patients with hypertension. Chlorthalidone causes slightly more hypokalemia than hydrochlorothiazide.

Login to subscribe for notifications.

The Multilingual ASCVD Risk Estimator is a simplified web-based version of the ASCVD Risk Estimator Plus app that provides clinicians with an efficient way to calculate a patient's estimated 10-year ...